Volume 4, Issue 2 (Spring 2023)
J Vessel Circ 2023, 4(2): 45-52 |
Back to browse issues page
Ethics code: IR.MUQ.REC.1400.169
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Khodadadi J, Vahidian M, Safai Moghadam A H, Sadeghi S, Moftakharzadeh S A, Nourabadi S et al . Investigating the Diagnostic Value of Vision Triage for Screening Patients With COVID-19. J Vessel Circ 2023; 4 (2) :45-52
URL: http://jvessels.muq.ac.ir/article-1-261-en.html
URL: http://jvessels.muq.ac.ir/article-1-261-en.html
Javad Khodadadi1 
, Mostafa Vahidian2 , Amir Hossein Safai Moghadam3 , Sepehr Sadeghi4 , Seyed Ahmad Moftakharzadeh * 1, Shabnam Nourabadi1 , Morteza Khoshgoftar5
, Mostafa Vahidian2 , Amir Hossein Safai Moghadam3 , Sepehr Sadeghi4 , Seyed Ahmad Moftakharzadeh * 1, Shabnam Nourabadi1 , Morteza Khoshgoftar5
1- Department of Infectious Diseases, Kamkar-Arabnia Medical Education Center, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran.
2- Department of Family and Community Medicine, Spiritual Health Research Center, School of Medicine, Qom University of Medical Sciences, Qom, Iran.
3- School of Medicine, Groningen University of Medical Sciences, Groningen, Netherlands.
4- Student Research Committee, Tehran University of Medical Sciences, Tehran, Iran.
5- Department of Pediatric Diseases, Faculty of Medicine, Hazrat Masoumeh (S) Medical Education Center, Qom University of Medical Sciences, Qom, Iran.
2- Department of Family and Community Medicine, Spiritual Health Research Center, School of Medicine, Qom University of Medical Sciences, Qom, Iran.
3- School of Medicine, Groningen University of Medical Sciences, Groningen, Netherlands.
4- Student Research Committee, Tehran University of Medical Sciences, Tehran, Iran.
5- Department of Pediatric Diseases, Faculty of Medicine, Hazrat Masoumeh (S) Medical Education Center, Qom University of Medical Sciences, Qom, Iran.
Abstract: (525 Views)
Background and Aim: This study aims to design and evaluate vision triage for screening patients with coronavirus according to the patient’s conditions for hospitalization or discharge of patients with COVID-19.
Materials and Methods: This study measured the tool’s value for the clinical triage of COVID-19 patients. In this form, the patient’s symptoms, underlying disease, contact with the COVID-19 patient in the last two weeks, and contact with healthcare personnel were evaluated. The diagnosis of COVID-19 was based on a positive real-time transcriptase polymerase chain reaction (PCR) test. We calculated the triage score for each patient based on the clinical form that uses signs and symptoms. In the next step, the sensitivity and specificity of the scored scale were analyzed.
Results: Out of 57 patients who had a negative scoring system, 15 patients (7.5%) had a positive test, and out of 143 patients for whom the scoring system reported a high number, 116 patients (58%) had a positive test. This scoring system’s sensitivity, specificity, and positive and negative predictive values were calculated as 88.5%, 60.8%, 81.1% and 73.6%, respectively.
Conclusion: This triage tool will be helpful in better management of patients with COVID-19. This system included clinical findings with high diagnostic accuracy.
Materials and Methods: This study measured the tool’s value for the clinical triage of COVID-19 patients. In this form, the patient’s symptoms, underlying disease, contact with the COVID-19 patient in the last two weeks, and contact with healthcare personnel were evaluated. The diagnosis of COVID-19 was based on a positive real-time transcriptase polymerase chain reaction (PCR) test. We calculated the triage score for each patient based on the clinical form that uses signs and symptoms. In the next step, the sensitivity and specificity of the scored scale were analyzed.
Results: Out of 57 patients who had a negative scoring system, 15 patients (7.5%) had a positive test, and out of 143 patients for whom the scoring system reported a high number, 116 patients (58%) had a positive test. This scoring system’s sensitivity, specificity, and positive and negative predictive values were calculated as 88.5%, 60.8%, 81.1% and 73.6%, respectively.
Conclusion: This triage tool will be helpful in better management of patients with COVID-19. This system included clinical findings with high diagnostic accuracy.
Type of Study: Research |
Subject:
cardiovascular diseases
Received: 2023/08/28 | Accepted: 2023/10/10 | Published: 2024/02/29
Received: 2023/08/28 | Accepted: 2023/10/10 | Published: 2024/02/29
References
1. Rezvan S, Nasiri B, Farahmand H, Ahmadi J, Noori E, Bazmandegan G, et al . Frequency of ABO blood groups in patients with COVID-19 referred to Ali Ibn Abi Taleb Hospital in Rafsanjan in 2020. J Vessel Circ. 2021; 2(4):171-8. [Link] [DOI:10.32598/JVC.2.4.64.7]
2. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020; 382(13):1199-207. [DOI:10.1056/NEJMoa2001316] [PMID] [PMCID] [DOI:10.1056/NEJMoa2001316]
3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. [DOI:10.1016/S0140-6736(20)30183-5] [PMID] [PMCID] [DOI:10.1016/S0140-6736(20)30183-5]
4. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-33. [DOI:10.1056/NEJMoa2001017] [PMID] [PMCID] [DOI:10.1056/NEJMoa2001017]
5. Phan LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HT, Le HQ, et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med. 2020; 382(9):872-4. [DOI:10.1056/NEJMc2001272] [PMID] [PMCID] [DOI:10.1056/NEJMc2001272]
6. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity. 2020; 109:102433. [DOI:10.1016/j.jaut.2020.102433] [PMID] [PMCID] [DOI:10.1016/j.jaut.2020.102433]
7. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-9. [DOI:10.1001/jama.2020.1585] [PMID] [PMCID] [DOI:10.1001/jama.2020.1585]
8. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020; 395(10223):507-513. [DOI:10.1016/S0140-6736(20)30211-7] [PMID] [DOI:10.1016/S0140-6736(20)30211-7]
9. Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021; 19(3):141-54. [DOI:10.1038/s41579-020-00459-7] [PMID] [PMCID] [DOI:10.1038/s41579-020-00459-7]
10. Wang L, Yang LM, Pei SF, Chong YZ, Guo Y, Gao XL, et al. CRP, SAA, LDH, and DD predict poor prognosis of coronavirus disease (COVID-19): A meta-analysis from 7739 patients. Scand J Clin Lab Invest. 2021; 81(8):679-86. [DOI:10.1080/00365513.2021.2000635] [PMID] [DOI:10.1080/00365513.2021.2000635]
11. Centers for Disease Control and Prevention (CDC). Interim infection prevention and control recommendations for hospitalized patients with Middle East respiratory syndrome coronavirus (MERS-CoV). Atlanta: Centers for Disease Control and Prevention; 2015. [Link]
12. Transplant Infectious Disease. Guidance on coronavirus disease 2019 (COVID-19) for transplant clinicians [Internet]. 2019 [Updated 2024 May 31]. Available from: [Link]
13. Ghorbani J, Safavi Naini A, Jahangirifard A, Raad N, Karimi-Galougahi M, Moradi A, et al. The effect of using the surgical mask on the status of cerebral oxygen saturation and end-tidal carbon dioxide in health care workers. J Otorhinolaryngol Facial Plast Surg. 2022; 8(1):1-7. [DOI:10.22037/orlfps.v8i1.37784]
14. Alfaraj SH, Al-Tawfiq JA, Gautret P, Alenazi MG, Asiri AY, Memish ZA. Evaluation of visual triage for screening of Middle East respiratory syndrome coronavirus patients. New Microbes New Infect. 2018; 26:49-52. [DOI:10.1016/j.nmni.2018.08.008] [PMID] [PMCID] [DOI:10.1016/j.nmni.2018.08.008]
15. Li J, Li S, Cai Y, Liu Q, Li X, Zeng Z, et al. Epidemiological and clinical characteristics of 17 hospitalized patients with 2019 novel coronavirus infections outside Wuhan, China. MedRxiv. 2020; [Unpublished]. [DOI:10.1101/2020.02.11.20022053] [DOI:10.1101/2020.02.11.20022053]
16. Noori E, Vahedian M, Rezvan S, Minaei N, Tabaraii R. The proposed scoring system for hospitalization or discharge of patients with COVID-19. J Emerg Pract Trauma. 2022; 8(1):60-3. [DOI:10.34172/jept.2021.08] [DOI:10.34172/jept.2021.08]
17. Salunke AA, Warikoo V, Kumar Pathak S, Nandy K, Mujawar J, Mendhe H, et al. A proposed ABCD scoring system for better triage of patients with COVID-19: Use of clinical features and radiopathological findings. Diabetes Metab Syndr. 2020; 14(6):1637-40. [DOI:10.1016/j.dsx.2020.08.019] [PMID] [PMCID] [DOI:10.1016/j.dsx.2020.08.019]
18. Salunke AA, Pathak SK, Dhanwate A, Warikoo V, Nandy K, Mendhe H, et al. A proposed ABCD scoring system for patient's self assessment and at emergency department with symptoms of COVID-19. Diabetes Metab Syndr. 2020; 14(5):1495-501. [DOI:10.1016/j.dsx.2020.07.053] [PMID] [PMCID] [DOI:10.1016/j.dsx.2020.07.053]
19. Duca A, Piva S, Focà E, Latronico N, Rizzi M. Calculated decisions: Brescia-COVID respiratory severity scale (BCRSS)/algorithm. Emerg Med Pract. 2020; 22(5 Suppl):CD1-2. [PMID]
20. Ji D, Zhang D, Xu J, Chen Z, Yang T, Zhao P, et al. Prediction for progression risk in patients with COVID-19 pneumonia: The CALL score. Clin Infect Dis. 2020; 71(6):1393-9. [DOI:10.1093/cid/ciaa414] [PMID] [PMCID] [DOI:10.1093/cid/ciaa414]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Owned by Qom University of Medical Sciences
Published by Qom University of Medical Sciences Press
eISSN: 2717-0357
Email: jvessels[at]muq.ac.ir
j.vessels.circul[at]gmail.com
